3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
fludarabine phosphate
10
Cyclophosphamide
8
Busulfan
8
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Antilymphocyte Serum
7
Tacrolimus
6
Methotrexate
5
Cyclosporine
5
thymoglobulin
4
Melphalan
4
Rituximab
3
Radiotherapy
3
Etoposide
3
Cord Blood Stem Cell Transplantation
3
Sirolimus
2
Ondansetron
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Carmustine
2
Calcium Dobesilate
2
Aprepitant
2
ruxolitinib
1
fludarabine
1
fedratinib
1
etoposide phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Neutrophilic, Chronic
×
Imatinib Mesylate
×
Clear all
No trials found.